Joris Winderickx
Corporate Officer/Principal bei reMYND NV
Aktive Positionen von Joris Winderickx
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Corporate Officer/Principal | 30.05.2012 | - |
Direktor/Vorstandsmitglied | 01.01.2002 | 30.05.2012 | |
Gründer | 09.11.2009 | - |
Karriereverlauf von Joris Winderickx
Ehemalige bekannte Positionen von Joris Winderickx
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Royal Flemish Chemical Society | Gründer | - | - |
ADx NeuroSciences NV
ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Direktor/Vorstandsmitglied | - | - |
Katholieke Universiteit Leuven | Corporate Officer/Principal | - | - |
Ausbildung von Joris Winderickx
Katholieke Universiteit Leuven | Doctorate Degree |
Statistik
International
Belgien | 5 |
Operativ
Director/Board Member | 2 |
Founder | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Commercial Services | 2 |
Consumer Services | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
Royal Flemish Chemical Society | |
ADx NeuroSciences NV
ADx NeuroSciences NV BiotechnologyHealth Technology ADx NeuroSciences NV develops proprietary state-of-the-art biomarker-assays diagnosing a wide variety of neurodegenerative diseases and conditions. The ADx tests provide unique access to early detection of Alzheimer's disease, Parkinson's disease, and traumatic brain injury. The company was founded in 2011 by Paul Appermont, Koen Dewaele, Hugo Vanderstichele and Eugeen Vanmechelen and is headquartered in Ghent, Belgium. | Health Technology |
- Börse
- Insiders
- Joris Winderickx
- Erfahrung